Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride, a hair loss treatment, works better and is more stable when delivered through specially prepared gels, leading to increased hair growth.

Noncoding dsRNA boosts hair growth by activating TLR3 and increasing retinoic acid.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Tirzepatide may improve hair loss by reducing insulin resistance.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Fire needle therapy's benefits and safety for alopecia areata need more evidence.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

High-intensity phototechnology, especially with other treatments, effectively improves quality of life for diffuse alopecia patients.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Finasteride helps brain function in rats with liver-related brain issues.

Intramuscular injection of 131I is a safe and effective way to induce hypothyroidism in rats without harming muscle tissue.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Two siblings had a rare immune disorder caused by a FOXN1 gene mutation.

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Accurate diagnosis and new therapies are crucial for effectively treating certain types of hair loss.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

Both LNG-IUD and systemic progestins are effective for fertility-sparing treatment, but close monitoring is needed due to recurrence risk.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.